(Q84789983)
Statements
Ki67 expression in the primary tumor predicts for clinical benefit and time to progression on first-line endocrine therapy in estrogen receptor-positive metastatic breast cancer (English)
Y Delpech
Y Wu
K R Hess
L Hsu
M Ayers
R Natowicz
C Coutant
E Barranger
G N Hortobagyi
D Mauro